(2E)-2-[[3-[2-fluoro-4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl]methylidene]-5-methyl-3H-inden-1-one
C21H17FN2O2 — CID 122414183
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2E)-2-[[3-[2-fluoro-4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl]methylidene]-5-methyl-3H-inden-1-one
(2E)-2-[[3-[2-fluoro-4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl]methylidene]-5-methyl-3H-inden-1-one (PubChem CID 122414183) has the molecular formula C21H17FN2O2 and a molecular weight of 348.38 g/mol. Its IUPAC name is (2E)-2-[[3-[2-fluoro-4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl]methylidene]-5-methyl-3H-inden-1-one.
Molecular Properties
| Compound Name | (2E)-2-[[3-[2-fluoro-4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl]methylidene]-5-methyl-3H-inden-1-one |
|---|---|
| PubChem CID | 122414183 |
| Molecular Formula | C21H17FN2O2 |
| Molecular Weight | 348.38 g/mol |
| Exact Mass | 348.13 |
| IUPAC Name | (2E)-2-[[3-[2-fluoro-4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl]methylidene]-5-methyl-3H-inden-1-one |
| SMILES | Cc1ccc2c(c1)C/C(=C\c1cc(-c3ccc(CO)cc3F)n[nH]1)C2=O |
| InChI | InChI=1S/C21H17FN2O2/c1-12-2-4-17-14(6-12)8-15(21(17)26)9-16-10-20(24-23-16)18-5-3-13(11-25)7-19(18)22/h2-7,9-10,25H,8,11H2,1H3,(H,23,24)/b15-9+ |
| InChIKey | KJHUMRCTTBEFJS-OQLLNIDSSA-N |
| XLogP | 3.84 |
| TPSA | 65.98 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 348.38 |
| LogP ≤ 5 | 3.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122414183 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.